The latest Headway Mental Health Report finds avoidable costs of more than €122 billion across Europe each year
Since 2017, Angelini Pharma and TEHA worked collaboratively on the Headway Initiative: a platform promoting reflection, analysis, dialogue and comparison in the management of Brain Health across Europe.